REFERENCES
- Riggs B.L., Melton L.J., III. Involutional osteoporosis. N. Engl. J. Med 1986; 314: 1676, [CSA]
- Ettinger B., Genant H.K., CEP. C. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann. Intern. Med 1987; 106: 40, [CSA]
- Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner 1991; 15: 175, [CROSSREF], [CSA]
- Heaney R.P., Saville P.D. Etidronate disodium in postmenopausal osteoporosis. Clin Pharmacol. Ther 1976; 20: 593, [CSA]
- Chae H.J., Kang J.S., Kim J.H., Kim C.W., Yoo S.K., Shin T.Y., Choi B., Kim H.R. Antiosteoporotic activity of Dae-Bo-Won-Chun in Ovariectomized rats. Phytotherapy Res 2001; 15: 53, [CROSSREF], [CSA]
- Wronski T.J., Yen C.F., Qi H., Dann L.M. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology 1993; 132: 823, [CROSSREF], [CSA]
- 7. Wartofsky, L. Osteoporosis: a growing concern for the thyroidologist. Thyroid Today 1998 11, 1.8
- McGowan J.A. Osteoporosis: assessment of bone loss and remodeling. Aging (Milano) 1993; 5: 81, [CSA]
- Roudebush R.E., Magee D.E., Benslay D.N., Bendele A.M., Bryant H.U. Effect of weight manipulation on bone loss due to ovariectomy and the protective effects of estrogen in the rats. Calcif. Tissue Int 1993; 53: 61, [CROSSREF], [CSA]
- Wronski T.J., Cintron M., Dann L.M. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif. Tissue Int 1998; 43: 179, [CSA]
- Mosekilde L., Eriksen E.F., Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol. Metab. Clin. North. Am 1990; 19: 35, [CSA]
- Mosekilde L., Melsen F., Bagger J.P., Myhre-Jensen O., Schwartz, Sorensen N. Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinol. (Copenh) 1976; 85: 515, [CSA]